Home

NICHOLAS J SIMON III

CIK 1221595 · last filed 2013-04-30

NICHOLAS J SIMON III is a corporate insider who has filed 23 SEC Form 4 insider transactions across 9 companies since 2007. The most recent filing, for RDUS, was dated Apr 30, 2013. Across all open-market trades the lifetime net is +$3.2M, making them a net buyer over the disclosed history. 54 SEC filings were submitted jointly with NICHOLAS GALAKATOS.

"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.

Loading insider history…
Disclosed Exposure

$0

Companies

9

Total Filings

23

Lifetime Open-Market Net

$3.21M

Filer Profile

Reported Address
THE JOHN HANCOCK TOWER
200 CLARENDON STREET, 54TH FLOOR
BOSTON, MA 02116
Related Filers
NICHOLAS GALAKATOS — 54 joint filings, latest 2016-09-29
KURT WHEELER — 47 joint filings, latest 2016-09-29
ANSBERT GADICKE — 44 joint filings, latest 2013-02-07
DENNIS HENNER — 44 joint filings, latest 2012-07-10
MICHAEL STEINMETZ — 44 joint filings, latest 2013-02-07
LUKE EVNIN — 39 joint filings, latest 2013-02-07
MPM BIOVENTURES III GP L.P. — 2 joint filings, latest 2006-12-21
MPM BIOVENTURES III LLC — 2 joint filings, latest 2006-12-21
Profile details as reported on the filer's SEC submissions — for individual insiders the address is often in care of the issuer. Related filers are identified from jointly filed SEC submissions and shared reported addresses. View filings on SEC EDGAR.

Holdings By Company

Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
Symbol Role Shares Price Disclosed Exposure Lifetime OM Net Filings Latest Filed
Radius Health, Inc. (RDUS) Delisted 10%+ Owner — $30.00 — $0 1 2013-04-30
HUMANIGEN, INC (KBIO) Delisted 10%+ Owner 2,319,401 — — $0 1 2013-02-07
Pernix Sleep, Inc. (SOMX) Delisted 10%+ Owner 362,558 — — -$5.27M 2 2012-07-10
ARYx Therapeutics, Inc. (ARYX) Delisted Director 5,368,974 — — $6.93M 8 2010-10-04
PONIARD PHARMACEUTICALS, INC. (PARDD) Delisted Director 6,435,538 — — $1.65M 6 2010-06-11
Altimmune, Inc. (PIP) Delisted 10%+ Owner — — — $0 1 2009-07-30
Pharmasset Inc (VRUS) Delisted 10%+ Owner 5,199 — — -$102.3K 1 2008-04-02
BARRIER THERAPEUTICS INC (BTRX) Delisted Director — — — $0 1 2007-06-08
COTHERIX INC (CTRX) Delisted Director 0 — — $0 2 2007-01-10

Recent Filings

23 filings
Insider activity across all companies, newest first. Form 4 rows are post-trade confirmations (buys, sells, grants, exercises). Notice (144) rows are pre-trade notices of intent to sell restricted or control stock under Rule 144 — they may not all execute. Compare adjacent dates to see which notices became actual sales.
Filed Symbol Action Net Shares Net $ Link
2013-04-30 Radius Health, Inc. (RDUS) Delisted Buy (P) — $0 EDGAR
2013-02-07 HUMANIGEN, INC (KBIO) Delisted Conv (C) +15,797,568 $0 EDGAR
2012-07-10 Pernix Sleep, Inc. (SOMX) Delisted Sell (S) −16,070,537 -$4.86M EDGAR
2010-10-04 ARYx Therapeutics, Inc. (ARYX) Delisted Buy (P) — $0 EDGAR
2010-08-17 ARYx Therapeutics, Inc. (ARYX) Delisted Buy (P) — $0 EDGAR
2010-06-11 PONIARD PHARMACEUTICALS, INC. (PARDD) Delisted Grant (A) +72,289 $0 EDGAR
2010-05-03 ARYx Therapeutics, Inc. (ARYX) Delisted Grant (A) — $0 EDGAR
2009-11-09 PONIARD PHARMACEUTICALS, INC. (PARDD) Delisted Sell (S) −494,962 -$4.05M EDGAR
2009-07-30 Altimmune, Inc. (PIP) Delisted Mixed — $0 EDGAR
2009-06-25 PONIARD PHARMACEUTICALS, INC. (PARDD) Delisted Grant (A) — $0 EDGAR
Showing 1–10 of 23
Page 1 of 3
Form 4 codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.